Health Professionals Petition WHO for Guidance: People Should Use Nasal Sprays to Combat COVID-19 Pandemic; Doctors Use in Treating Patients
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
WASHINGTON -- Businesswire -- Today, a consortium of health professionals petitioned the World Health Organization to issue Guidance calling on: all people to use nasal sprays to combat the COVID-19 pandemic; doctors to use them in treating COVID-19 patients; and, Member-States to implement public health policies promoting the use of nasal sprays to both prevent and treat COVID-19.
The petition asks the WHO to promulgate guidance that promotes the use of nasal sprays with data indicating that they are antiviral (blocks viral adhesion), virucidal (kills or deactivates the virus), anti-bacterial (block bacteria, in particular pneumonia bacteria) and bactericidal (kills bacteria, in particular pneumonia bacteria).
“We have data showing that certain nasal sprays don’t just wash away the virus. Certain sprays actually block, deactivate and/or kill the virus,” said Dr. Gustavo Ferrer, a respiratory illness expert who has conducted research on the use of nasal sprays to combat COVID-19, and is among the petitioners.
As a result, the petition calls specifically for WHO Guidance to focus on the use of nasal sprays that contain Xylitol and grapefruit seed extract. Recent studies have found that these natural components used together are antiviral (they block SARS-CoV-2 adhesion to the nasal membrane) and virucidal (they kill or deactivate the virus). One such spray, Xlear, is currently widely available in the US. Xlear has been used by millions of people worldwide, over twenty-plus years, without any adverse effects reported.
Additionally, a new, small clinical study found Xlear lessens the severity and shortens the duration of COVID-19 illnesses, and reduces the risk of further transmission, which is why the petition calls for guidance to doctors to use it as an adjunct to current treatments.
“Nasal sprays are proven safe, inexpensive, non-invasive, easy to use and you can get them off-the-shelf at your local store around the world. There is a growing body of data that sprays, in particular Xlear, can help combat the COVID-19 pandemic. It’s pure commonsense,” Nathan Jones, CEO of Xlear said.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210125005242/en/
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
출처:Xlear, Inc.
보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포
Copyright © 뉴스와이어. 무단전재 및 재배포 금지.
- NHN KCP, 경기도형 오픈이노베이션 사업 참여… 스타트업과 성장 동력 모색 - 뉴스와이어
- 투썸플레이스, 비비×투썸 ‘달디단 밤양갱’ 음료 여름 한정 론칭 - 뉴스와이어
- 엔비피헬스케어, 특허청 ‘지식 재산 경영 인증’ 획득… 국내외 특허등록 95건 돌파 - 뉴스와이
- 다시 깨어난 3500억 숙취해소제 시장… 스틱형 성장세 주목 - 뉴스와이어
- 현대자동차, ST1 카고 및 카고 냉동 출시 - 뉴스와이어
- 우리은행, 삼성월렛에 학생증 카드 담는다 - 뉴스와이어
- 동원F&B, 간편하게 발라먹는 ‘동원참치 스프레드&튜나페’ 출시 - 뉴스와이어
- 대웅제약 펙수클루, 1분기 처방액 57% 성장… 3세대 위장약 P-CAB 성장 이끌어 - 뉴스와이어
- 한글 문화상품의 매력을 세계에 알린다 - 뉴스와이어
- 비즈니스북스 ‘1천만 원으로 시작하는 수도권 아파트 투자의 기적’ 출간 - 뉴스와이어